Sign inJoin waitlistJoin the waitlist

Tsewang Tashi

Associate Professor · Univ of Utah Sch of Med

Credentials: · · · · · · ·

History

Univ of Utah Sch of Med
Present
Univ of Utah Sch of Med
Present

Hematology and Medical Oncology
University of Utah Health
2007–2010
Internal Medicine
Creighton University
2004–2007
Mackay Memorial Hospital
2003–2004
CHANG GUNG UNIV, COLL OF MED, GUEISHAN, TAO-YUAN, TAIWAN
1999–2003

Research

A genetic mechanism for Tibetan high-altitude adaptation
Nature Genetics · 2014 · 329 citations
Evolutionary history of Tibetans inferred from whole-genome sequencing
PLoS Genetics · 2017 · 79 citations
Avapritinib versus Placebo in Indolent Systemic Mastocytosis
NEJM Evidence · 2023 · 73 citations

Josef Prchal
17 papers
Prithviraj Bose
9 papers
Abdulraheem Yacoub
7 papers
Brandi Reeves
7 papers
John Mascarenhas
7 papers
Ghaith Abu-Zeinah
6 papers
Ruben Mesa
6 papers
Stephen Oh
6 papers
SC
Sonia Cerquozzi
5 papers
Apar Ganti
4 papers
Lindsay Rein
4 papers
Lucia Masarova
4 papers

Clinical trials

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2029
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2029
Avapritinib With Decitabine in Patients With SM-AHN
Site PI · Recruiting · Phase 1
H. Lee Moffitt Cancer Center and Research Institute
2024–2027